A-41988
From Wikipedia, the free encyclopedia
Identifiers | |
---|---|
|
|
CAS Number | 52763-30-1 |
PubChem (CID) | 3085018 |
ChemSpider | 2341998 |
ChEMBL | CHEMBL303312 |
Chemical and physical data | |
Formula | C28H32FNO2 |
Molar mass | 433.556 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
A-41988 (BW29Y) is an analgesic drug which acts as a cannabinoid agonist. It was developed by Abbott Laboratories in the 1970s,[1][2] and researched for potential use in the treatment of glaucoma,[3] but never commercialised.
See also[edit]
References[edit]
- ^ Winn, M.; Arendsen, D.; Dodge, P.; Dren, A.; Dunnigan, D.; Hallas, R.; Hwang, K.; Kyncl, J.; Lee, Y. H.; Plotnikoff, N.; Young, P.; Zaugg, H. (1976). "Drugs derived from cannabinoids. 5. Delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains". Journal of Medicinal Chemistry. 19 (4): 461–471. doi:10.1021/jm00226a003. PMID 817021.
- ^ Guterman A, Somani P, Bachand RT. Clinical Pharmacology and Therapeutics 1979; 25:227.
- ^ Tiedeman, J. S.; Shields, M. B.; Weber, P. A.; Crow, J. W.; Cocchetto, D. M.; Harris, W. A.; Howes, J. F. (1981). "Effect of synthetic cannabinoids on elevated intraocular pressure". Ophthalmology. 88 (3): 270–277. doi:10.1016/s0161-6420(81)35052-0. PMID 7015221.
This cannabinoid related article is a stub. You can help Wikipedia by expanding it. |